ABOUT 3D-HUB-O
A unique platform in the South of France
The 3D-Hub-O platform was created in 2019 and benefits from the label of Canceropole SUD, which has helped fund the equipment and remuneration of the platform’s engineers. The platform has received the IBiSA label in 2022. The platform’s staff are committed to a quality approach that promotes continuous improvement.
3D-Hub-O specializes in the production, manipulation and analysis of organoids from normal and tumor tissues. It aims to put its expertise at the service of the community (academic and industry), to be a first-rate physiological platform for research on living pathological tissues, and to be committed to improving human health through its contribution to personalized medicine in compliance with current regulations.
The 3D-Hub-O platform participates in knowledge transfer through customized training of specific organoid culture carried out by platform staff. The management is committed to the technological evolution of the services offered in order to meet the platform’s competitiveness and increase its attractiveness.
3D-Hub-O is located at the Cancer Research Center of Marseille (CRCM) and the Paoli-Calmettes Institute
Keywords associated: Organoids, tumoroids, stem cells, personalized medicine, molecule screening, anti-cancer therapies
DR GERALDINE GUASCH
Scientific director of 3D-Hub-O
This video was produced with the financial support of the Institut Cancer et Immunologie
Supervisory authorities and funding partners
